CAAS Capital Management’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

CAAS Capital Management’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-253,434	Closed	-$18.4M	–	946
2021 Q3	$18.4M	Buy	+253,434	New	+$18.3M	0.37%	58
2021 Q2	–	Sell	-74,029	Closed	-$3.59M	–	1149
2021 Q1	$3.59M	Buy	+74,029	New	+$4.02M	0.04%	434
2020 Q4	–	Sell	-35,036	Closed	-$1.65M	–	871
2020 Q3	$1.65M	Buy	+35,036	New	+$1.16M	0.04%	282

Other funds holding NBP

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cederberg Capital London, United Kingdom $186M AUM 21.27% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ZAM

Zeal Asset Management Central, Hong Kong $39.4M AUM 38.83% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CAAS Capital Management's NBP Position: Q4 2021 in Review

CAAS Capital Management sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q4 2021, closing a stake of 253,434 shares — an estimated $18.4M sold.

CAAS Capital Management first reported a position in NBP in Q3 2020 and held it in 3 quarters. The position peaked at $18.4M in Q3 2021. 132 funds tracked by Wall St. Rank hold NBP as of Q4 2021.

CAAS Capital Management reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q4 2021 after selling out during the quarter.
CAAS Capital Management sold 253,434 NovaBridge Biosciences American Depositary Shares shares in Q4 2021, an estimated $18.4M.
CAAS Capital Management first reported a position in NovaBridge Biosciences American Depositary Shares in Q3 2020 and held it in 3 quarters.
CAAS Capital Management's NovaBridge Biosciences American Depositary Shares position peaked at $18.4M in Q3 2021.
132 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q4 2021.

Based on CAAS Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.